Open AccessHistomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer
Author(s) -
Paul M. Schneider,
Stephan Baldus,
Ralf Metzger,
Martin Köcher,
Rudolf Bongartz,
Elfriede Bollschweiler,
Hartmut Schaefer,
J. Thiele,
Hans Peter Dienes,
R.P. Mueller,
Arnulf H. Hoelscher
Publication year - 2005
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/01.sla.0000186170.38348.7b
Subject(s) - medicine , esophageal cancer , esophagectomy , grading (engineering) , neoadjuvant therapy , lymph node , lymphadenectomy , univariate analysis , proportional hazards model , chemoradiotherapy , chemotherapy , cancer , oncology , gastroenterology , multivariate analysis , civil engineering , breast cancer , engineering
We sought to quantitatively and objectively evaluate histomorphologic tumor regression and establish a relevant prognostic regression classification system for esophageal cancer patients receiving neoadjuvant radiochemotherapy.